This effect occurs mostly through erythrocyte pathways such as Hb decrease, therefore we should pay attention to and prevent osteoporosis complications in patients with higher HbA1c levels, particularly in the presence of certain blood diseases (such as anemia and other diseases that may lead to a decrease in hemoglobin). This evidence concerns the gene GSTM1 and blood disease.